Skip to main content
. 2019 Oct 30;17(1):174–186. doi: 10.1111/iwj.13254

Table 6.

NPWTi‐d with ROCF‐V use: statements and survey results

Consensus statement Yes No Consensus
NPWTi‐d may be considered for use in adequately cleansed and debrided wounds 13/13 (100%) 0/13 (0%) Yes
NPWTi‐d may be considered for use in clean wounds 12/13 (92%) 1/13 (8%) Yes
NPWTi‐d may be considered for use in contaminated wounds 12/13 (100%) 1/13 (8%) Yes
NPWTi‐d may be considered for use in wounds with heavy bioburden 11/13 (85%) 2/13 (15%) Yes
NPWTi‐d may be considered for use in acutely infected wounds 8/12 (67%) 4/12 (33%) No
NPWTi‐d may be considered for use in chronically infected wounds 11/13 (85%) 2/13 (15%) Yes
NPWTi‐d may be considered for use in wounds that are difficult to granulate 13/13 (100%) 0/13 (0%) Yes

Abbreviation: NPWTi‐d, negative pressure wound therapy with instillation and dwell time.